Advertisement

Pathophysiology and Natural History of Aortic Regurgitation

  • Masao DaimonEmail author
Chapter

Abstract

Aortic regurgitation (AR) causes left ventricular (LV) volume overload through the regurgitant flow from the aorta into the left ventricle (LV) due to incomplete aortic valve closure in diastole. There are a wide variety of causes of AR including not only changes to the leaflets themselves but also geometric changes to the perivalvular tissues, such as aortic root enlargement. Furthermore, AR causes progressive myocardial injury by means of complex mechanisms, such as both LV volume overload and increased afterload, myocardial ischemia, and energy loss due to turbulence. In addition, when compensatory mechanisms for these myocardial injury factors become inadequate, cardiac failure ensues for which the prognosis is poor. For this reason, when significant LV enlargement and/or systolic dysfunction is observed in severe AR, then surgery is required before patients develop symptomatic cardiac failure. It is essential to comprehend the pathophysiology and natural history of AR to make an appropriate diagnosis of AR and determine the optimal therapeutic strategy.

References

  1. 1.
    Ma WG, Zheng J, Zhu JM, Liu YM, Li M, Sun LZ. Aortic regurgitation caused by Behçet’s disease: surgical experience during an 11-year period. J Card Surg. 2012;27:39–44.CrossRefGoogle Scholar
  2. 2.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57–e185.CrossRefGoogle Scholar
  3. 3.
    Nitenberg A, Foult JM, Antony I, Blanchet F, Rahali M. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries. J Am Coll Cardiol. 1988;11:478–86.CrossRefGoogle Scholar
  4. 4.
    Stugaard M, Koriyama H, Katsuki K, Masuda K, Asanuma T, Takeda Y, et al. Energy loss in the left ventricle obtained by vector flow mapping as a new quantitative measure of severity of aortic regurgitation: a combined experimental and clinical study. Eur Heart J Cardiovasc Imaging. 2015;16:723–30.CrossRefGoogle Scholar
  5. 5.
    Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303–71..CrossRefGoogle Scholar
  6. 6.
    Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999;99:1851–7.CrossRefGoogle Scholar
  7. 7.
    Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1–142.CrossRefGoogle Scholar
  8. 8.
    Detaint D, Messika-Zeitoun D, Maalouf J, Tribouilloy C, Mahoney DW, Tajik AJ, et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study. JACC Cardiovasc Imaging. 2008;1:1–11.CrossRefGoogle Scholar
  9. 9.
    Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation. 2002;106:2687–93.CrossRefGoogle Scholar
  10. 10.
    Pizarro R, Bazzino OO, Oberti PF, Falconi ML, Arias AM, Krauss JG, et al. Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol. 2011;58:1705–14.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Clinical LaboratoryThe University of Tokyo HospitalTokyoJapan

Personalised recommendations